Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
Status:
Recruiting
Trial end date:
2028-03-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-arm study to evaluate the safety and dosimetry of
Lutathera in adolescent patients 12 to <18 years old with somatostatin receptor positive
GEP-NETs and PPGLs. The study will enroll at least 8 patients in the GEP-NET cohort and as
many adolescents with PPGL as possible in the exploratory PPGL cohort.